Dashboard
Healthy long term growth as Operating profit has grown by an annual rate 30.39%
The company has declared Positive results for the last 6 consecutive quarters
With ROCE of 19.4, it has a Attractive valuation with a 1.9 Enterprise value to Capital Employed
Majority shareholders : Non Institution
Market Beating Performance
Stock DNA
Commodity Chemicals
INR 54 Cr (Micro Cap)
12.00
40
0.00%
0.43
19.59%
2.33
Total Returns (Price + Dividend) 
Ritesh Intl. for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Ritesh International Faces Intense Selling Pressure Amid Consecutive Losses
Ritesh International Ltd, a key player in the Commodity Chemicals sector, is currently experiencing significant selling pressure, with the stock registering a sharp decline and an absence of buyers in the market. The stock has recorded consecutive losses over the past two days, signalling distress selling and heightened market caution.
Read More
Ritesh International Hits Upper Circuit Amidst Unprecedented Buying Interest
Ritesh International Ltd, a key player in the Commodity Chemicals sector, has witnessed extraordinary buying momentum today, hitting the upper circuit with only buy orders in queue and no sellers on the books. This rare market phenomenon signals strong investor enthusiasm and the potential for a multi-day circuit scenario as the stock continues to outperform benchmarks and sector peers.
Read More
Ritesh International Hits Upper Circuit Amidst Unprecedented Buying Interest
Ritesh International Ltd, a key player in the Commodity Chemicals sector, has witnessed extraordinary buying interest today, resulting in an upper circuit scenario with only buy orders in the queue. This rare market phenomenon highlights a potential multi-day circuit situation, underscoring the stock’s strong momentum despite recent volatility.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
12-Nov-2025 | Source : BSENewspaper Publication for Financial Results 30.09.2025
Financial Results For Quarter/Half Year Ended 30.09.2025
10-Nov-2025 | Source : BSEFinancial Results for Quarter/Half Year ended 30.09.2025
Board Meeting Outcome for Outcome Of Board Meeting 10.11.2025
10-Nov-2025 | Source : BSEIn continuation to intimation dated 03.11.2025 we wish to inform you that Board of Directors in its meeting held today the 10.11.2025 the board meeting commenced at 11:00 A.M. and concluded at 11.30 A.M. inter alia considered and approved the following: The Un-Audited Financial Results for the Quarter/Half Year ended 30.09.2025. The Limited Review Report on the Un-Audited Financial Results issued by M/s Ashok Shashi & Co. the Statutory Auditor of the Company.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Non Institution
None
Held by 3 Schemes (0.06%)
Held by 0 FIIs
Rijul Arora (16.6%)
Brisk Securities Ltd (2.01%)
49.46%
Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is 10.53% vs -6.83% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is 178.95% vs -81.19% in Jun 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 41.04% vs -36.41% in Sep 2024
Growth in half year ended Sep 2025 is 278.95% vs -82.81% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'24
YoY Growth in nine months ended Dec 2024 is -8.44% vs -6.64% in Dec 2023
YoY Growth in nine months ended Dec 2024 is -43.17% vs -0.87% in Dec 2023
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 54.17% vs -33.94% in Mar 2024
YoY Growth in year ended Mar 2025 is 4,225.00% vs -107.62% in Mar 2024






